Latest News & Features
Refine Search
Americas
A US district court yesterday gave its opinion on how a group of disputed patent claims must be construed in a patent infringement case between Eisai and Novartis and several generic drug makers. 18 March 2015
Americas
Dublin-based pharmaceutical company Actavis has completed its acquisition of Allergan for $71 billion. 17 March 2015
Europe
Law firm Cooley has added to its newly-opened London office with the hire of life sciences lawyers John Wilkinson and Nicola Maguire. 17 March 2015
Americas
The US Court of Appeals for the Federal Circuit yesterday threw out a damages sum of $48 million, some of which had been awarded to Yale University, finding that a lower court did not properly interpret the claims in the disputed patent. 17 March 2015
Americas
Florida-based healthcare company Diabetic Care RX, which operates as Patient Care America, has asked for a declaratory judgment that it does not infringe a patent owned by Pentec Health by providing nutritional supplements to dialysis clinics. 16 March 2015
Big Pharma
An Advocate General in the Court of Justice of the European Union, Niilo Jääskinen, has clarified how the regulation for supplementary protection certificates should be interpreted concerning medicinal products made with a combination of active ingredients. 13 March 2015
Americas
A judge at the US District Court for the District of Delaware has issued a preliminary injunction against CryoLife, finding that the medical device maker’s PerClot Topical haemostatic powder infringes rival company C R Bard’s patent. 12 March 2015
Americas
In the battle for marketing approval of a biosimilar version of Neupogen under the BPCIA, applicant Sandoz stymied Amgen’s chance to join the so-called patent dance. Andrew Williams of McDonnell Boehnen Hulbert & Berghoff ponders the implications. 12 March 2015
Americas
Japanese company Otsuka Pharmaceutical has sued drugs company Wockhardt for patent infringement at the US District Court for the District of New Jersey. 11 March 2015
Americas
Pharmaceutical company Janssen has sued drugs businesses Celltrion and Hospira in one of the first patent infringement actions brought under the Biologics Price Competition and Innovation Act. 10 March 2015